APA (7th ed.) Citation

Pennock, M., Halmos, B., III, W. B., Cheng, H., Gucalp, R., & Ohri, N. (2021). Predictors of Early Durvalumab Discontinuation After Chemoradiotherapy for Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics, 111(3), e448. https://doi.org/10.1016/j.ijrobp.2021.07.1265

Chicago Style (17th ed.) Citation

Pennock, M.M, B. Halmos, W.R. Bodner III, H. Cheng, R. Gucalp, and N. Ohri. "Predictors of Early Durvalumab Discontinuation After Chemoradiotherapy for Non-Small Cell Lung Cancer." International Journal of Radiation Oncology, Biology, Physics 111, no. 3 (2021): e448. https://doi.org/10.1016/j.ijrobp.2021.07.1265.

MLA (9th ed.) Citation

Pennock, M.M, et al. "Predictors of Early Durvalumab Discontinuation After Chemoradiotherapy for Non-Small Cell Lung Cancer." International Journal of Radiation Oncology, Biology, Physics, vol. 111, no. 3, 2021, p. e448, https://doi.org/10.1016/j.ijrobp.2021.07.1265.